We diligently vet all our vendors assuring their appropriate licensing is in place, purchasing only from select and reputable partners who are checked for their bona fide status.

Masters maintains the highest quality values through ethical and legal sourcing from our select list of reliable and trusted partners in the developed world.  This ensures that our international customers have access to the widest choice of the latest in advanced and established prescription and well-known branded pharmaceuticals (or their generic equivalents) covering innovative speciality medicines that are either unlicensed, discontinued or in short supply as well as orphan drugs for rare diseases.

Wherever possible we aim to source directly from the manufacturer; we work with a selection of preferred vendors who are subject to participate in our supplier approval process to verify their authenticated, commercial and quality status.  In order to ensure they are in compliance with their licence, we have a formal process in place to routinely check that it is being upheld with the regulatory bodies.

Ensuring safety, efficacy and value in the products:

  • We operate a robust Quality Management System
  • We check the bona fide status of all our suppliers
  • We are compliant with the requirements of Good Distribution Practice (GDP)
  • We offer cold chain and ambient storage from our three storage centres
  • We hold a Wholesale Dealers License (WDL)
  • We are fully regulated in the territories in which we operate
  • We hold Home Office Controlled Drugs Licenses

We operate in a fully licensed and compliant framework that is independently regulated, and quality assured, ensuring integrity of supply chain (including cold chain) throughout; including maintaining full batch traceability and where necessary the implementation of a Pharmacovigilance programme providing the customer a guarantee of safe, efficient distribution through our centres in the USA, Central America and Europe.

Most importantly and beneficially, the above ensures your products are sourced reliably, quickly and cost-effectively and at the forefront of our minds - a simple goal – patient wellbeing. 

One of the ways that Masters is expected to prevent falsified medicines entering the supply chain is the requirement to establish “Bona Fides” of both its Suppliers and Customers.  This is a legal obligation placed on us by our Health Authority and is included within the terms of our regulatory license which requires us to ensure we purchase medicinal products only from either licensed manufacturers or wholesalers, and that our Customer has a right to receive, handle and provide medicinal products to the health care profession or patients.

Wednesday 31 May 2017

From Thursday, 1st June, 2017, all patients in the USA requiring deflazacort should contact the EMFLAZA CaresTM program on 1-844-EMFLAZA...

Wednesday 18 January 2017

Masters Speciality Pharma is pleased to announce its appointment as Amgen (Europe) GmbH’s exclusive supplier.

Find out more